Prevalence of primary HIV- associated thrombocytopenia in a central South African population
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i9.16724Keywords:
HIV- associated thrombocytopeniaAbstract
-
References
Vaughan JL, Wiggil TM, Alli N, Hodkinson K. The prevalence of HIV seropositivity and associated cytopenias in full blood counts processed at an academic laboratory in Soweto, South Africa. S Afr Med J 2017;107(3):264-269. https://doi.org/10.7196/samj.2017.v107i3.11206
Scaradavou A. HIV-related thrombocytopenia. Blood Rev 2002;16(1):73-76. https://doi. org/10.1054/blre.2001.0188
Vannappagari V, Nkhoma ET, Atashili J, Laurent SS, Zhao H. Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets 2011;22(8):611-618. https://doi.org/10.3109/09537104.2011.582526
Ambler KL, Vickars LM, Leger CS, et al. Clinical features, treatment, and outcome of HIV- associated immune thrombocytopenia in the HAART era. Adv Haem 2012;2012:910954. https:// doi.org/10.1155%2F2012%2F910954
O’Bryan TA, Okulicz JF, Bradley WP, Ganesan A, Wang X, Agan BK. Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia. BMC Rs Notes 2015;8(1):1-5.
Getawa S, Aynalem M, Bayleyegn B, Adane T. The global prevalence of thrombocytopenia among HIV-infected adults: A systematic review and meta-analysis. Int J Infec Dis 2021;105:495-504. https://doi.org/10.1016/j.ijid.2021.02.118
Vishnu P, Aboulafia DM. Haematological manifestations of human immune deficiency virus infection. Brit J Haematol 2015;171(5):695-709. https://doi.org/10.1111/bjh.13783
Beintheknow. The science of HIV and AIDS – overview. Avert.org, 2022. https://www.avert.org/ professionals/hiv- science/overview (accessed 10 April 2022).
Statistics South Africa. Statistical resease p0302. Mid-year population estimates. Pretoria: Stats SA, 2021. http://www.statssa.gov.za/publications/P0302/P03022021.pdf (accessed 10 April 2022).
Jali AG, Nkambule BB. Prevalence and aetiology of moderate and severe thrombocytopenia in a tertiary and quaternary centre in KwaZulu-Natal. Afr J Labor Med 2020;9(1):1-5. https://doi. org/10.4102/ajlm.v9i1.799
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
